ERT Respiratory

Managing risk and generating high quality data is notably difficult in respiratory trials. Complex protocols, lack of training, data collection and analysis inconsistencies create uncertainty about a patient’s eligibility to participate in a trial, patient safety and a compound’s efficacy. At ERT, we’ve completed 550 respiratory trials, enrolled 500K patients, managed 45K + sites in 93 countries, and supported data in 105 languages. Demand data quality and breathe easy in your respiratory trials with ERT’s solutions.

Case Studies

• Global Pharmaceutical Company Proves Efficacy of Bronchodilator For COPD Patients
• Global Pharmaceutical Company Drives Data Acceptability Over 95%

Articles

• Three Respiratory Trial Strategies That Won’t Leave You Breathless

New Product Announcements

• ERT Introduces Advanced Solution to Capture, Measure and Analyze Lung Clearance Index (LCI)

New Service Announcements

• ERT Introduces Express Overread Service For Respiratory Clinical Trials

For more information, go to ert.com or email sales@ert.com